Gold futures gained on Thursday as the dollar stayed subdued after data showing a smaller than expected increase in U.S. private sector employment helped raise optimism the Federal Reserve will start cutting rates sometime early […]

Save articles for later Add articles to your saved list and come back to them any time. National Australia Bank boss Ross McEwan says there could be one more interest rate rise in the next […]

Save articles for later Add articles to your saved list and come back to them any time. The self-declared status of one of China’s largest shadow banks as “severely insolvent” has revealed another crack in […]

After ending the previous session sharply higher, treasuries saw further upside over the course of the trading day on Wednesday. Bond prices showed a lack of direction early in the session but managed to finish […]

Crude oil prices fell sharply on Wednesday, sliding for a second straight session, amid rising concerns about the outlook for energy demand. Data showing a sharp jump in crude oil inventories in the U.S. also […]

Treasuries moved sharply higher during trading on Thursday, extending the strong upward move seen over the course of the previous session. Bond prices gave back some ground after an early surge but remained firmly positive. […]

Save articles for later Add articles to your saved list and come back to them any time. After three months of losing market share in home lending, all eyes are on the Commonwealth Bank to […]

Gold prices climbed to five-month highs on Friday, with rising Middle East tensions pushing up the demand for the safe-haven metal. However, amid concerns about the outlook for interest rates, the yellow metal gave up […]

Save articles for later Add articles to your saved list and come back to them any time. Banks, telcos and tech companies should collaborate more closely on combatting fraud, the assistant treasurer has said, as […]

Genentech, Inc., a subsidiary of the Roche Group (RHHBY.PK) announced Friday new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces brain lesions in people with relapsing […]